Livzon Pharmaceutical Group Inc Cash Flow Quality Index
Livzon Pharmaceutical Group Inc cash flow quality index. Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Quality Index of 2.32x as of December 2025. Operating cash flow of CN¥625.70 Million exceeds net income of CN¥269.15 Million, indicating high earnings quality where cash backs reported profits. Explore Livzon Pharmaceutical Group Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Livzon Pharmaceutical Group Inc (1998–2025)
Cash flow quality index of Livzon Pharmaceutical Group Inc from 1998 to 2025. Historical Cash Flow Quality Index for Livzon Pharmaceutical Group Inc across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Livzon Pharmaceutical Group Inc net asset quality index to measure how much of total assets are equity-financed.
Livzon Pharmaceutical Group Inc Cash Flow Quality Index by Year (1998–2025)
Livzon Pharmaceutical Group Inc cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Livzon Pharmaceutical Group Inc. For the full cash flow conversion analysis, see how efficiently does Livzon Pharmaceutical Group Inc generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | CN¥3.18 Billion | CN¥2.02 Billion | ▲ +21.6% |
| 2024 | 1.29x | CN¥2.98 Billion | CN¥2.30 Billion | ▼ -24.5% |
| 2023 | 1.71x | CN¥3.25 Billion | CN¥1.90 Billion | ▲ +20.8% |
| 2022 | 1.42x | CN¥2.77 Billion | CN¥1.96 Billion | ▲ +45.5% |
| 2021 | 0.97x | CN¥1.90 Billion | CN¥1.95 Billion | ▼ -3.9% |
| 2020 | 1.01x | CN¥2.16 Billion | CN¥2.13 Billion | ▼ -16.2% |
| 2019 | 1.21x | CN¥1.77 Billion | CN¥1.46 Billion | ▲ +3.2% |
| 2018 | 1.17x | CN¥1.27 Billion | CN¥1.08 Billion | ▲ +294.2% |
| 2017 | 0.30x | CN¥1.32 Billion | CN¥4.43 Billion | ▼ -81.8% |
| 2016 | 1.63x | CN¥1.28 Billion | CN¥784.35 Million | ▲ +9.5% |
| 2015 | 1.49x | CN¥927.79 Million | CN¥622.64 Million | ▲ +15.0% |
| 2014 | 1.30x | CN¥717.39 Million | CN¥553.62 Million | ▲ +54.3% |
| 2013 | 0.84x | CN¥439.99 Million | CN¥523.99 Million | ▼ -32.8% |
| 2012 | 1.25x | CN¥593.96 Million | CN¥475.22 Million | ▼ -31.6% |
| 2011 | 1.83x | CN¥708.20 Million | CN¥387.80 Million | ▲ +30.5% |
| 2010 | 1.40x | CN¥633.30 Million | CN¥452.49 Million | ▲ +45.3% |
| 2009 | 0.96x | CN¥494.88 Million | CN¥513.79 Million | ▼ -79.7% |
| 2008 | 4.73x | CN¥345.18 Million | CN¥72.91 Million | ▲ +896.9% |
| 2007 | 0.47x | CN¥248.55 Million | CN¥523.38 Million | ▼ -68.7% |
| 2006 | 1.52x | CN¥226.46 Million | CN¥149.33 Million | ▲ +9.5% |
| 2005 | 1.39x | CN¥161.07 Million | CN¥116.27 Million | ▲ +2.9% |
| 2004 | 1.35x | CN¥181.46 Million | CN¥134.74 Million | ▼ -45.5% |
| 2003 | 2.47x | CN¥300.01 Million | CN¥121.47 Million | ▼ -0.2% |
| 2002 | 2.48x | CN¥213.65 Million | CN¥86.32 Million | ▲ +19.2% |
| 2001 | 2.08x | CN¥155.15 Million | CN¥74.71 Million | ▲ +39.7% |
| 2000 | 1.49x | CN¥38.52 Million | CN¥25.90 Million | ▼ -94.5% |
| 1999 | 27.25x | CN¥246.23 Million | CN¥9.04 Million | ▲ +6209.8% |
| 1998 | -0.45x | CN¥-18.21 Million | CN¥40.83 Million | — |